- Home
- AAMI vs INSP Comparison
AAMI vs INSP Comparison
Compare AAMI & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAMI | INSP |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | AAMI | INSP |
|---|---|---|
| Price | $51.78 | $52.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $53.00 | ★ $101.07 |
| AVG Volume (30 Days) | 248.9K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $29.60 | $8.44 |
| Revenue Next Year | $12.41 | $8.60 |
| P/E Ratio | $23.86 | ★ $11.02 |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $22.60 | $53.11 |
| 52 Week High | $57.03 | $172.95 |
Technical Indicators
Market Signals| Indicator | AAMI | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 28.53 |
| Support Level | $46.04 | N/A |
| Resistance Level | $56.16 | $84.26 |
| Average True Range (ATR) | 1.59 | 2.80 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 50.45 | 10.84 |
Price Performance
Historical ComparisonAbout AAMI Acadian Asset Management Inc.
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.